Compound heterozygous variants in F7 gene causing severe factor VII deficiency without bleeding: A genotypic and laboratory analysis
Blood Cells, Molecules, and Diseases · 2026-09 · 120 · 103025
DOI: 10.1016/j.bcmd.2026.103025 ↗Kurz gefasst
Fallbericht in der Zeitschrift Blood Cells, Molecules, and Diseases, 2026-09. Verfasst von Fengjiao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, the First Affilia…. Hauptthemen laut MEDLINE: Factor VII Deficiency, Factor VII, Heterozygote. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Coagulation factor VII (FVII) is a vitamin K-dependent glycoprotein and serves as a key initiator of the extrinsic coagulation pathway. Hereditary FVII deficiency is an autosomal recessive genetic disorder with a highly heterogeneous bleeding phenotype. It is the most prevalent among rare hereditary bleeding disorders. Among the various genotypes, complex heterozygous variants are of particular importance in hereditary coagulation factor deficiency. This study reports a case of a patient with hereditary FVII deficiency. The patient presented for planned surgery for renal cysts. Preoperative evaluation revealed abnormal coagulation indicators; therefore, the surgery was temporarily postponed. Further investigations to clarify the cause revealed markedly prolonged prothrombin time (PT), significantly reduced FVII activity (FVII:C), and mildly decreased FVII antigen (FVII:Ag). Complex heterozygous variants (p.Ile303Thr and p.Cys389Gly) were identified, confirming the diagnosis of hereditary FVII deficiency. Thrombin generation assay (TGA) and thromboelastography (TEG) suggested that the patient's global coagulation capacity was not substantially impaired. No specific treatment was administered, and regular follow-up was conducted. In this compound heterozygous patient with markedly reduced FVII:C without bleeding, TGA and TEG may offer a better assessment of bleeding risk than FVII:C alone, and family screening facilitates identification and management of at-risk individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Laboratory Medicine, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China.
- Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.…
Zitieren
APA
Wang, F., Liu, M., Jin, Y., Wu, C., Lu, Y., Qin, L., Wang, M., & Yang, L. (2026). Compound heterozygous variants in F7 gene causing severe factor VII deficiency without bleeding: A genotypic and laboratory analysis. Blood Cells, Molecules, and Diseases, 120, 103025. https://doi.org/10.1016/j.bcmd.2026.103025
Vancouver
Wang F, Liu M, Jin Y, Wu C, Lu Y, Qin L, et al. Compound heterozygous variants in F7 gene causing severe factor VII deficiency without bleeding: A genotypic and laboratory analysis. Blood Cells, Molecules, and Diseases. 2026;120:103025. doi:10.1016/j.bcmd.2026.103025
BibTeX
@article{Wang2026,
author = {Wang, Fengjiao and Liu, Meina and Jin, Yanhui and Wu, Conglian and Lu, Yifan and Qin, Langyi and Wang, Mingshan and Yang, Lihong},
title = {Compound heterozygous variants in F7 gene causing severe factor VII deficiency without bleeding: A genotypic and laboratory analysis},
journal = {Blood Cells, Molecules, and Diseases},
year = {2026},
volume = {120},
pages = {103025},
doi = {10.1016/j.bcmd.2026.103025}
}
EUVIMED